aid: agenovir
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/agenovir.png
name: Agenovir
description: Agenovir Corporation was a biotechnology company founded in 2014 to develop a novel class
  of human therapeutics targeting diseases caused by latent or persistent viral reservoirs. Built on
  CRISPR/Cas9 and other nuclease technology from the Stephen Quake lab at Stanford, it designed and
  simulated nucleases in silico at scale to disrupt intracellular viral DNA. It raised a $10.6M Series A
  led by DCVC (Data Collective) with Celgene and Lightspeed Venture Partners, and was acquired by Vir
  Biotechnology in 2018. It is a therapeutics company with no public developer, API, or SDK surface.
url: https://raw.githubusercontent.com/api-evangelist/agenovir/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: Vir Biotechnology
x-acquired-year: 2018
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Therapeutics
- CRISPR
- Gene Editing
- Antiviral
- Life Sciences
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 0
  pass: local-v1